BNOX
Closed
Bionomics Ltd Adr
5.01
+0.13 (+2.66%)
Last Update: 24 Feb 2025 17:30:00
Yesterday: 4.88
Day's Range: 4.6 - 5.01
Send
sign up or login to leave a comment!
When Written:
2.6
Bionomics Ltd is a biopharmaceutical company that develops and commercializes treatments for central nervous system disorders and cancer. The company is based in Australia and has a primary listing on the Australian Securities Exchange (ASX: BNO) and a secondary listing on the OTCQX market in the United States under the ticker symbol BMICY.
Bionomics has a pipeline of drug candidates in various stages of development, including BNC210 for anxiety and depression, BNC101 for cancer, and BNC375 for neuropathic pain. The company also has partnerships with several pharmaceutical companies for the development and commercialization of its drug candidates.
As of August 2021, Bionomics had a market capitalization of approximately AUD 198 million and had reported a net loss of AUD 8.5 million for the year ended June 30, 2020.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Bionomics has a pipeline of drug candidates in various stages of development, including BNC210 for anxiety and depression, BNC101 for cancer, and BNC375 for neuropathic pain. The company also has partnerships with several pharmaceutical companies for the development and commercialization of its drug candidates.
As of August 2021, Bionomics had a market capitalization of approximately AUD 198 million and had reported a net loss of AUD 8.5 million for the year ended June 30, 2020.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








